Audrey Fan1, Praveen Gulaka1, Mohammad Mehdi Khalighi2, Bin Shen1, Aileen Hoehne1, Prachi Singh1, Jun H Park1, Dawn Holley1, Frederick T Chin1, and Greg Zaharchuk1
1Radiology, Stanford University, Stanford, CA, United States, 2Applied Science Lab, GE Healthcare, Menlo Park, CA, United States
Synopsis
The
ability to noninvasively image cerebral blood flow (CBF) would help with
assessment of many cerebrovascular disorders including stroke. We compared
simultaneous PET-MRI measurements of CBF by arterial spin labeling MRI and the
[15O]-water PET reference standard in healthy volunteers. ASL and
PET revealed similar spatial distributions of perfusion in the brain and
reliably detected CBF augmentation due to Diamox administration. ASL MRI also
demonstrated lower scan-rescan coefficient of variation across the gray matter
relative to PET. Going forward, we will perform kinetic modeling of absolute
CBF from [15O]-water PET and consider potentially different
radiotracer arterial input functions (derived from the PET-MRI images
themselves) that occur in different brain perfusion states.Purpose
Cerebral
blood flow (CBF) measurements are critical to assessment of many
cerebrovascular disorders including stroke. In the past 15 years, arterial spin
labeling (ASL) MRI has gained traction as a promising, noninvasive way to
quantify CBF [1]. However, ASL is not routinely used in the clinic because it
lacks validation. Most validation studies to date have compared ASL to the [15O]-water
PET reference standard in separate imaging sessions, such that natural CBF
fluctuations due to different physiological states, diet, and diurnal cycles
confound the comparison [2, 3].
This
study performs a head-to-head comparison between pseudo-continuous ASL and [15O]-water
PET reference scans collected simultaneously on a hybrid PET-MRI system. We aim
(1) to compare the CBF response of the brain to Diamox as measured by PET and
by MRI; and (2) to evaluate the scan-rescan reproducibility of CBF measurements
by each image modality. We also discuss future opportunities in using
image-based arterial input functions (AIF) from the hybrid system to improve
CBF quantification.
Methods
Five
healthy volunteers (two female; ages 24-40 years) were scanned on a 3T time of
flight PET-MRI hybrid system (GE Healthcare, Milwaukee, WI). PET imaging with
15-25 mCi of [15O]-water was performed before and after
administration of 15mg/kg of Diamox, which increases CBF. PET scans commenced
immediately after each tracer injection and coincided with ASL MRI scans. Four
subjects received successive repeat PET scans and all subjects received repeat
ASL scans before Diamox. Relative maps of CBF were created from integration of
PET counts over the first 2 minutes after tracer injection and normalization
for tracer dose.
The ASL
scan parameters included pseudo-continuous labeling with label duration of
1500ms and post-label delay of 2025ms; TR/TE = 4850/10.7 ms; slice thickness =
4mm; bandwidth = 62.5kHz; and spiral readout (8 arms of 512 samples).
Quantitative CBF maps were calculated for using consensus values for the
longitudinal relaxation of arterial blood and tag efficiency [4]. All perfusion
images were registered to a common stereotactic space (the Montreal
Neurological Institute template) with FSL software. Scan-rescan reproducibility
of relative CBF by PET and of absolute CBF by ASL was assessed using
coefficient of variation (COV) = standard deviation of the repeat scans / mean
between the scans.
Results
Group
averages of relative CBF by PET and baseline CBF by ASL showed similar spatial
distribution across the 5 volunteers (Figure
1). Absolute gray matter CBF measured by ASL increased from 48.9±8
ml/100g/min at rest to 68.1±12 ml/100g/min after Diamox administration.
For the same
volunteer, we assumed a similar AIF following each tracer injection, such that
comparing PET images before and after Diamox revealed the relative CBF
augmentation (after accounting for tracer dose). Both modalities revealed
comparable CBF augmentation in the gray and white matter due to Diamox (Figure 2), with slightly higher CBF
increase of 44.9% by ASL and 39.9% by PET.
COV maps of scan-rescan reproducibility for
each image modality are shown averaged over all subjects (Figure 3). The reproducibility of successive scans was similar for
PET and MRI; ASL showed slightly lower COV (11.5%) across the gray matter
compared to PET (14.6%). The COV maps tended to be higher for white matter,
which is expected due to the low perfusion signal in those regions.
Future Prospects
Hybrid
PET-MRI allows simultaneous observations of the same brain perfusion state by
ASL MRI and the [15O]-water PET reference standard for validation. Our
initial findings suggest that ASL can reliably detect increases in CBF during
Diamox administration consistent with PET measurements and with lower COV.
In
future work, we will focus on kinetic modeling of quantitative CBF from [15O]-water
PET. This analysis can potentially leverage hybrid PET-MRI information by
identifying image-based AIFs from regions of interest within carotid arteries on
co-localized, high-resolution MRI angiograms. Knowledge of the artery location
from high-resolution MRI can be used to mitigate spill-over effects that
contaminate the AIF peak shape and height, and thus absolute CBF values.
Furthermore, AIFs determined at the carotid may be a more accurate
representation of tracer arrival to the brain. For instanced, the [15O]-water
AIF may have a higher peak and arrive more quickly to the brain carotids after
Diamox compared to baseline (Figure 4).
This difference in AIF would not have been detected from traditional arterial
sampling at a radial artery of the arm. Thus, simultaneous PET-MRI offers dual
information that can help to validate ASL as a clinical and scientific tool to
study brain perfusion, and to improve its measurement by both modalities.
Acknowledgements
This work is supported by the Stanford Neuroscience Institute Interdisciplinary Scholar fellowship and GE Healthcare.References
[1] Detre J.A., et al. Applications of arterial spin labeled MRI in the brain. J Magn Reson Imag 35 (2012): 1026-1037.
[2] Heijtel D.F.R., et al., Accuracy and Precision of Pseudo-Continuous Arterial Spin Labeling Perfusion During Baseline and Hypercapnia: A Head-to-Head Comparison with 15O-H2O Positron Emission Tomography. Neuroimage 92 (2014): 182-192.
[3] Chen Y., et al. Test-Retest Reliability of Arterial Spin Labeling with Common Strategies. J Magn Reson Imag 33 (2011): 940-949.
[4] Alsop D.C., et al., Recommended Implementation of Arterial Spin-Labeled Perfusion MRI for Clinical Applications: A Consensus of the ISMRM Perfusion Study Group and the European Consortium for ASL in Dementia. Magn Reson Med 73 (2015): 102-116.